A therapeutic approach to low-grade serous ovarian carcinoma
Low-grade serous ovarian cancer (LGSOC) has less aggressive behavior and a better clinical outcome than high-grade serous ovarian cancer (HGSOC). Considering that this malignancy is relatively chemoresistant, surgery is the keystone of treatment, with a strong recommendation for maximal cytoreductio...
Main Authors: | Branka Petrić-Miše, Dinka Šundov |
---|---|
Format: | Article |
Language: | English |
Published: |
University Hospital for Tumors
2020-01-01
|
Series: | Libri Oncologici |
Subjects: | |
Online Access: | https://hrcak.srce.hr/file/364268 |
Similar Items
-
Therapeutic Approach to Low-Grade Serous Ovarian Carcinoma: State of Art and Perspectives of Clinical Research
by: Angiolo Gadducci, et al.
Published: (2020-05-01) -
Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences
by: Fedro Alessandro Peccatori, et al.
Published: (2018-03-01) -
Targeted Agents in Ovarian Carcinoma
by: Murat Oz, et al.
Published: (2016-06-01) -
Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors
by: Alice Indini, et al.
Published: (2021-05-01) -
Further Understanding of High-Grade Serous Ovarian Carcinogenesis: Potential Therapeutic Targets
by: Voutsadakis IA
Published: (2020-10-01)